AIRA Matrix and Gestalt Team To Revolutionize Diagnostics with AI QC Platform
Mumbai, India and Spokane, Washington, 25th March 2025 – AIRA Matrix, a leading provider of AI-powered quality control (QC) solutions, has teamed up with Gestalt, a major digital pathology player, to boost diagnostic accuracy in labs worldwide. The partnership will integrate AIRA Matrix’s AIRAQC platform into Gestalt’s PathFlow, giving pathologists an AI-driven tool to streamline workflows and get better results.
AIRAQC automates and enhances QC in pathology. By embedding this in Gestalt’s systems, labs will be able to analyze samples faster and more accurately. Pathologists will make better decisions and diagnostics will be more efficient and reliable.
“We’re thrilled to partner with Gestalt to expand the reach of AIRAQC and deliver transformative AI capabilities to pathology labs,” said Marco Comianos, Head of Commercial Operations – US at AIRA Matrix.
Gestalt’s COO and Chief Strategy Officer, Lisa-Jean Clifford added “The partnership between AIRA Matrix and Gestalt is another step in the journey to advance pathology through technology to meet the evolving healthcare needs. Together our companies will arm labs with the latest tools to get diagnostic accuracy, quality and meaningful metrics from the start of the diagnostic process.”
This partnership will bring big benefits to pathology labs by making them faster, more precise and data-driven. By combining AI with digital pathology, AIRA Matrix and Gestalt are making way for smarter, more reliable diagnostics that will lead to better patient outcomes.
Read Latest Stories:
TIER IV Brings Japan’s First Steering Wheel-Free Robotaxi
Meta Enforces Transparency for AI-Altered Political Content in Canada
Darktrace Federal Wins U.S. Approval to Guard Sensitive Government Data with AI
